✦ LIBER ✦

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

✍ Scribed by Carlo Aul; Wolfgang Schneider

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 704 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19891101)64:9<1812::aid-cncr2820640909>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Low-dose cytosine arabinoside (Ara-C) th

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

✍ Jane N. Winter; Daina Variakojis; Ellen R. Gaynor; Richard A. Larson; Kenneth B. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Evaluation of continuous infusion low-do

Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes

✍ Dr. Christopher R. Chitambar; Joseph A. Libnoch; William G. Matthaeus; Robert C. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 2 views

The role of timing of high-dose cytosine

The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

✍ William G. Woods; Frederick B. Ruymann; Beatrice C. Lampkin; Jonathan D. Buckley 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Toxicity of high-dose cytosine arabinosi

Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy a pediatric oncology group study

✍ Cameron K. Tebbi; Jeffrey Krischer; Donald J. Fernbach; Donald H. Mahoney; Carlo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views